Delivery Order SPE2DB25D3201-SPE2DB25FNVJD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $23,157.77 to AmerisourceBergen Drug Corp for the supply of Dasatinib 80 mg tablets (30-count units) under a firm fixed-price contract type. The order was competitively awarded without set-aside designation and carries an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $24,781.68 delivery order to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets in quantities of 30, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the agency. The pharmaceutical product will be delivered to the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $47,320.66 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units). This competitive award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Dasatinib 100 mg tablets in a 30-count package, with a contract ceiling value of $4,816.96. This non-set-aside, competitively awarded delivery order employs firm fixed pricing and is scheduled for completion by April 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,193.03 to AmerisourceBergen Drug Corp for Dasatinib 50 mg tablets (60-count supply) on August 11, 2025, with a completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Dasatinib 100 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $37,364.76, with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Dasatinib 50 mg, with a contract value of $12,233.56. This is a firm fixed price delivery order awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract does not utilize a set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 6, 2025, for the supply of Dasatinib 80 mg tablets in quantities of 30 units. The contract is valued at $4,479.02 with a firm fixed price structure and an ultimate completion date of August 7, 2025. This award represents a non-set-aside competitive procurement and serves as a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Dasatinib 100 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $39,326.10 and an ultimate completion date of September 9, 2025. The contract carries no set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dasatinib 140 mg tablets in a quantity of 30 units, with a contract ceiling value of $3,744.14. This competitively awarded, firm fixed-price delivery order was established on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVJDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,448.37 to AmerisourceBergen Drug Corp for the supply of Dasatinib 80 mg tablets (30-count units) with an ultimate completion date of August 5, 2025. The contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. As a prime pharmaceutical vendor to the federal government, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and federal healthcare systems worldwide. The underlying IDC serves as the contracting vehicle enabling AmerisourceBergen to fulfill pharmaceutical support requirements for customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 8/4/25 |